Provided by Tiger Fintech (Singapore) Pte. Ltd.

Janux Therapeutics, Inc.

29.25
-0.0300-0.10%
Volume:384.03K
Turnover:11.31M
Market Cap:1.76B
PE:-17.41
High:29.94
Open:28.92
Low:28.76
Close:29.28
52wk High:71.71
52wk Low:21.73
Shares:60.15M
Float Shares:44.97M
Volume Ratio:0.79
T/O Rate:0.85%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6802
EPS(LYR):-1.2836
ROE:-12.48%
ROA:-10.49%
PB:1.80
PE(LYR):-22.79

Loading ...

Company Profile

Company Name:
Janux Therapeutics, Inc.
Exchange:
NASDAQ
Establishment Date:
2017
Employees:
109
Office Location:
10955 Vista Sorrento Parkway,Suite 200,San Diego,California,United States
Zip Code:
92130
Fax:
- -
Introduction:
Janux Therapeutics, Inc., a clinical stage biopharmaceutical company, develops immunotherapies based on Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr) platforms technology to treat patients suffering from cancer. The company's clinical candidates comprise JANX007, a prostate-specific membrane antigen or PSMA-TRACTr, which is in Phase 1 clinical trial in adults for the treatment of metastatic castration-resistant prostate cancer (mCRPC) and the vasculature of other tumors; and JANX008, an epidermal growth factor receptor or EGFR-TRACTr that is in Phase 1 clinical trial for the treatment of multiple solid cancers, including colorectal cancer, squamous cell carcinoma of the head and neck, non-small cell lung cancer, and renal cell carcinoma. Its development pipeline also consists of discovery stage products. The company has strategic research collaboration agreement with Merck Sharp & Dohme Corp. to develop TRACTr product candidates. Janux Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California.

Directors

Name
Position
David Campbell
President and Chief Executive Officer, Director
Alana McNulty
Director
Eric Dobmeier
Director
Jake Simson
Director
Natasha Hernday
Director
Ron Barrett
Director
Sheila Gujrathi
Director
Vickie Capps
Director
Winston Kung
Director

Shareholders

Name
Position
David Campbell
President and Chief Executive Officer, Director
Andy Meyer
Chief Business Officer
Charles Winter
Chief Technical Officer
Thomas DiRaimondo
Chief Scientific Officer
Zachariah McIver
Chief Medical Officer